Epidemiology of gastric cancer in Ukraine from 2014–2022: Rate, sex and age
DOI:
https://doi.org/10.32782/2786-7684/2025-1-21Keywords:
сombined-fixed dise drugs, Helicobacter pylori, eradication, gastric cancer, incidence rateAbstract
Introduction. Gastric cancer remains a significant global health concern, with 1.09 million cases and 769,000 deaths reported in 2020. Its prevalence is influenced by Helicobacter pylori infections, dietary habits, and healthcare disparities. Preventive measures have reduced incidence and mortality, although regional differences persist. East Asia has achieved progress through national screening programs, while lower-income regions, such as Eastern Europe, face ongoing challenges. Research aims. This study examined gastric cancer trends in Ukraine from 2014 to 2022, focusing on the total number of cases, gender distribution, and age demographics. Comparisons with global trends highlight areas for intervention. Materials and methods. Data were obtained from the National Cancer Registry of Ukraine. Cases classified under ICD-10 were analysed for rate, sex and age. Trends were assessed using exponential regression and R² calculations with MedCalc® Software version 22.009. Results and discussion. The number of cancer cases in Ukraine fluctuated, peaking in 2019 before falling in 2020 due to the COVID-19 pandemic, which disrupted screenings. Gastric cancer cases declined from 8,350 in 2014 to 5,401 in 2022, reflecting global trends driven by dietary improvements and reduced H. pylori infections. However, progress in Ukraine was slower due to limited screening access. Men consistently accounted for 61% of cases, mirroring global risk factors such as smoking and occupational exposure, while oestrogen may have offered women some protection. Patients over 45 comprised more than 94% of cases, consistent with global data showing an increased risk among older adults due to prolonged carcinogen exposure. Late diagnoses and limited access to specialised care worsened the outcomes for older patients. Conclusion. Gastric cancer trends in Ukraine show global progress as well as local challenges. Although incidence is declining, gender disparities and late-stage diagnoses persist. Expanding early detection, addressing healthcare inequalities and promoting preventive measures are vital to further reduce incidence and mortality.
References
The International Agency for Research on Cancer (IARC). Global cancer observatory [Internet]. 2022 [cited 2024 Dec 21]. Available from: https://gco.iarc.fr/en
Collatuzzo G, Santucci C, Malvezzi M, La Vecchia C, Boffetta P, Negri E. Trends in gastric cancer mortality 1990–2019 in 36 countries worldwide, with predictions to 2025, and incidence, overall and by subtype. Cancer Medicine. 2023 Feb 23;12(8):9912-25. doi: https://doi.org/10.1002/cam4.5685.Epub 2023 Feb 23.
Semenov VV, Kriachkova LV, Shestakova N, Khanov V, Donchenko H, Balashova O, et al. Gastric cancer epidemiology from 2009 to 2019 in Dnipro Region, Ukraine. Cancer Epidemiology. 2023 Feb;82:102315. doi: https://doi.org/10.1016/j.canep.2022.102315.
Chernov YO, Haysanovska V, Makarenko OV. Gastric cancer in Ukraine: Epidemiologic data and its nosological structure between 2003 and 2020. Gastroenterology Review. 2024 Jan 1;16(4):428-433. doi: https://doi.org/10.5114/pg.2024.134840.
Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies. International Journal of Molecular Sciences. 2020 Jun 4;21(11):4012. doi: https://doi.org/10.3390/ijms21114012.
Shin WS, Xie F, Chen B, Yu P, Yu J, To KF, et al. Updated epidemiology of gastric cancer in Asia: Decreased incidence but still a big challenge. Cancers (Basel). 2023 May 6;15(9):2639-9. doi: https://doi.org/10.3390/cancers15092639.
Wang S, Zheng R, Arnold M, Abnet C, Zeng H, Zhang S, et al. Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype. International Journal of Cancer. 2022 Nov 1;151(9):1447-61. doi: https://doi.org/10.1002/ijc.34158.
Cancer in Ukraine 2019-2020. Incidence, mortality, prevalence and other relevant statistics / Fedorenko Z., Michailovich Yu., Goulak L. et al. – www.ncru.inf.ua/publications/- Accessed 20.11.2024. Available from: http://ncru.inf.ua/publications/index.htm
Chicco D, Warrens MJ, Jurman G. The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation. PeerJ Computer Science. 2021 Jul 5;7(5):e623. doi: https://doi.org/10.7717/peerj-cs.623.
Ma J, Zhu C, Li W, Qiu Z, Yang J, Ge L, et al. The effect of delayed oncology surgery on survival outcomes for patients with gastric cancer during the COVID-19 pandemic: Evidence-based strategies. Frontiers in Oncology. 2022 May 19;12. doi: https://doi.org/10.3389/fonc.2022.780949.
Dubrovina N, Gulášová I, Babečka J. Tendencies of the mortality rates from esophageal cancer in the EU countries and Ukraine. Kharkiv Surgical School. 2020 Apr 20;101(2):102-7. https://doi.org/10.37699/2308-7005.2.2020.21.
Ryzhov A, Bray F, Ferlay J, Fedorenko Z, Goulak L, Gorokh Y, et al. Evaluation of data quality at the National Cancer Registry of Ukraine. Cancer Epidemiology. 2018 Apr; 53:156-65. doi: https://doi.org/10.1016/j.canep.2018.02.002.
Weltermann T, Schulz C, Macke L. Effect of frequently prescribed drugs on gastric cancer risk. Best Practice & Research Clinical Gastroenterology. 2021 Mar;50–51:101741. doi: https://doi.org/10.1016/j.bpg.2021.101741.
Debraekeleer A, Remaut H. Future perspective for potential Helicobacter pylori eradication therapies. Future Microbiology. 2018 May;13(6):671-87. doi: https://doi.org/10.2217/fmb-2017-0115.
